ABDA-Database Archive
inlcudes list of already deleted German drugs
ABDA-Database Archive in a nutshell
The ABDA Database Archive lists 244,520 German Drugs taken off the market and deleted from the ABDA Database after their approval expired.
The Archive goes back until November 2003
Suitable for:
Pharma Industry, Pharma Trade, Health Insurance, Regulatory
Source: ABDATA PHARMA-DATA-SERVICE
Eschborn, Germany
Related subscription
This database can be accessed after purchasing the subscription package ‘Drug Dictionaries’, ‘Drug Pricing’ or ‘Premium’
What customers say
The use of the ABDA database CAVE is very valuable for teaching at the Pharmacological Institute because there is no other complete directory of all drugs approved in Germany. There is also no other program as good and reliable as the Cave module for testing interactions, which we regularly use for course tasks.
These databases could also be interesting for you
Related posts
Pharma Pricing Germany: Navigating Costs, Compliance and Transparency
Pharmaceutical pricing in Germany is unique in Europe – offering initial free pricing yet governed by strict mechanisms like AMNOG benefit assessments, reference pricing, and rebate contracts. In this comprehensive guide, we explain pharma pricing in Germany for...
European Drug Pricing Database: Comprehensive Pricing Insights for Healthcare Professionals
Access to an accurate, up-to-date European drug pricing database is essential for healthcare professionals in Germany, Austria, and Switzerland. Whether you’re calculating reimbursement, comparing market prices, or sourcing alternatives during shortages, having...
Pharmaceutical Market Access Germany: Navigating Approval, Pricing, and Reimbursement
Pharmaceutical market access in Germany is a critical step for any drug developer aiming to tap into Europe’s largest pharmaceutical market. With a population of 84 million and annual pharmaceutical revenues exceeding €56.9 billion in 2021, Germany offers vast...
